Antidote strategies to reverse anticoagulation with TB‐402, a long‐acting partial inhibitor of factor VIII

E-ISSN： 1538-7836|10|7|1371-1378

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.10, Iss.7, 2012-07, pp. : 1371-1378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tadalafil: a long-acting PDE5 inhibitor for the management of erectile dysfunction

By Seftel Allen D

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 185-196

Future Medicine

Access to resources Recommend Favorite

von Willebrand factor: factor VIII protector and friend

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 11, 2012-11 ,pp. : 2324-2327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacological characterization of ZYDPLA1, a novel long‐acting dipeptidyl peptidase‐4 inhibitor 一种新型的长效二肽基肽酶‐4抑制剂ZYDPLA1的药理特性

JOURNAL OF DIABETES, Vol. 7, Iss. 5, 2015-09 ,pp. : 708-717

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐Acting Reversible Contraception for Adolescents

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 3, 2015-06 ,pp. : 253-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquired Inhibitor to Factor VIII in a Nonhemophiliac Patient

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 34, Iss. 6, 1986-06 ,pp. : 472-474

John Wiley & Sons Inc

Access to resources Recommend Favorite